Literature DB >> 24119135

Conophylline suppresses hepatic stellate cells and attenuates thioacetamide-induced liver fibrosis in rats.

Norio Kubo1, Rie Saito, Kunihisa Hamano, Masahiro Nagasawa, Fumiaki Aoki, Izumi Takei, Kazuo Umezawa, Hiroyuki Kuwano, Itaru Kojima.   

Abstract

BACKGROUND & AIMS: Conophylline (CnP) is a vinca alkaloid purified from a tropical plant and inhibits activation of pancreatic stellate cells. We investigated the effect of CnP on hepatic stellate cells (HSC) in vitro. We also examined whether CnP attenuates hepatic fibrosis in vivo.
METHOD: We examined the effect of CnP on the expression of α-smooth muscle actin (α-SMA) and collagen-1, DNA synthesis and apoptosis in rat HSC and Lx-2 cells. We also examined the effect of CnP on hepatic fibrosis induced by thioacetamide (TAA).
RESULTS: In rat HSC and Lx-2 cells, CnP reduced the expression of α-SMA and collagen-1. CnP inhibited DNA synthesis induced by serum. CnP also promoted activation of caspase-3 and induced apoptosis as assessed by DNA ladder formation and TUNEL assay. In contrast, CnP did not induce apoptosis in AML12 cells. We then examined the effect of CnP on TAA-induced cirrhosis. In TAA-treated rats, the surface of the liver was irregular and multiple nodules were observed. Histologically, formation of pseudolobules surrounded by massive fibrous tissues was observed. When CnP was administered together with TAA, the surface of the liver was smooth and liver fibrosis was markedly inhibited. Collagen content was significantly reduced in CnP-treated liver.
CONCLUSION: Conophylline suppresses HSC and induces apoptosis in vitro. CnP also attenuates formation of the liver fibrosis induced by TAA in vivo.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  apoptosis; cirrhosis; collagen; fibrosis; stellate cell

Mesh:

Substances:

Year:  2013        PMID: 24119135     DOI: 10.1111/liv.12328

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  12 in total

Review 1.  Cancer-associated fibroblasts in hepatocellular carcinoma.

Authors:  Norio Kubo; Kenichiro Araki; Hiroyuki Kuwano; Ken Shirabe
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

Review 2.  Therapeutic activity of plant-derived alkaloid conophylline on metabolic syndrome and neurodegenerative disease models.

Authors:  Kazuo Umezawa; Itaru Kojima; Siro Simizu; Yinzhi Lin; Hitomi Fukatsu; Naoki Koide; Yukiomi Nakade; Masashi Yoneda
Journal:  Hum Cell       Date:  2017-12-16       Impact factor: 4.174

3.  The plant alkaloid conophylline inhibits matrix formation of fibroblasts.

Authors:  Takehiko Tezuka; Akinobu Ota; Sivasundaram Karnan; Katsuhiko Matsuura; Kazuhisa Yokoo; Yoshitaka Hosokawa; Davide Vigetti; Alberto Passi; Sonoko Hatano; Kazuo Umezawa; Hideto Watanabe
Journal:  J Biol Chem       Date:  2018-10-30       Impact factor: 5.157

4.  Conophylline inhibits non-alcoholic steatohepatitis in mice.

Authors:  Yukiomi Nakade; Kazumasa Sakamoto; Taeko Yamauchi; Tadahisa Inoue; Yuji Kobayashi; Takaya Yamamoto; Norimitsu Ishii; Tomohiko Ohashi; Yoshio Sumida; Kiyoaki Ito; Haruhisa Nakao; Yoshitaka Fukuzawa; Kazuo Umezawa; Masashi Yoneda
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

Review 5.  Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities.

Authors:  Chen Lu; Dawei Rong; Betty Zhang; Wubin Zheng; Xuehao Wang; Ziyi Chen; Weiwei Tang
Journal:  Mol Cancer       Date:  2019-08-29       Impact factor: 27.401

6.  Kaempferol attenuates liver fibrosis by inhibiting activin receptor-like kinase 5.

Authors:  Taifu Xu; Shan Huang; Qianrong Huang; Zhiyong Ming; Min Wang; Rongrui Li; Yinnong Zhao
Journal:  J Cell Mol Med       Date:  2019-07-05       Impact factor: 5.310

7.  Nintedanib inhibits intrahepatic cholangiocarcinoma aggressiveness via suppression of cytokines extracted from activated cancer-associated fibroblasts.

Authors:  Takahiro Yamanaka; Norifumi Harimoto; Takehiko Yokobori; Ryo Muranushi; Kouki Hoshino; Kei Hagiwara; Dolgormaa Gantumur; Tadashi Handa; Norihiro Ishii; Mariko Tsukagoshi; Takamichi Igarashi; Hiroshi Tanaka; Akira Watanabe; Norio Kubo; Kenichiro Araki; Ken Shirabe
Journal:  Br J Cancer       Date:  2020-02-04       Impact factor: 7.640

8.  Conophylline Suppresses Angiotensin II-Induced Myocardial Fibrosis In Vitro via the BMP4/JNK Pathway.

Authors:  S Q Zhang; Y N Bao; L Y Lv; X H Du; Y C Wang
Journal:  Bull Exp Biol Med       Date:  2021-07-24       Impact factor: 0.804

9.  Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts.

Authors:  Norihiro Ishii; Kenichiro Araki; Takehiko Yokobori; Kei Hagiwara; Dorgormaa Gantumur; Takahiro Yamanaka; Tadashi Handa; Mariko Tsukagoshi; Takamichi Igarashi; Akira Watanabe; Norio Kubo; Norifumi Harimoto; Atsushi Masamune; Kazuo Umezawa; Hiroyuki Kuwano; Ken Shirabe
Journal:  Cancer Sci       Date:  2018-12-13       Impact factor: 6.716

10.  Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice.

Authors:  Tomohiko Ohashi; Yukiomi Nakade; Mayu Ibusuki; Rena Kitano; Taeko Yamauchi; Satoshi Kimoto; Tadahisa Inoue; Yuji Kobayashi; Yoshio Sumida; Kiyoaki Ito; Haruhisa Nakao; Kazuo Umezawa; Masashi Yoneda
Journal:  PLoS One       Date:  2019-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.